Yuhan Corp Preferred Total Liabilities
Yuhan Corp Preferred total liabilities. Based on the latest financial reports, Yuhan Corp Preferred (000105) has total liabilities worth ₩936.71 Billion KRW (≈ $634.79 Million USD) as of March 2026. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check 000105 financial resilience to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Yuhan Corp Preferred (2014–2025)
Total liabilities of Yuhan Corp Preferred from 2014 to 2025. This chart illustrates how Yuhan Corp Preferred's total liabilities have evolved over time, based on quarterly financial data. Explore Yuhan Corp Preferred long-term investment intensity to see how much of total assets are deployed in long-term investments.
Yuhan Corp Preferred Competitors by Total Liabilities
The table below lists competitors of Yuhan Corp Preferred ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
SelfWealth Limited
AU:SWF
|
Australia | AU$344.06 Million |
|
Sensus Healthcare Inc
NASDAQ:SRTS
|
USA | $4.94 Million |
|
Arovella Therapeutics Ltd
AU:ALA
|
Australia | AU$1.33 Million |
|
PJ Metal Co. Ltd
KQ:128660
|
Korea | ₩79.80 Billion |
|
Chemfab Alkalis Limited
NSE:CHEMFAB
|
India | Rs1.88 Billion |
|
AML3D Ltd
AU:AL3
|
Australia | AU$7.53 Million |
|
Fuel Tech Inc
NASDAQ:FTEK
|
USA | $5.83 Million |
|
Li Cheng Enterprise Co Ltd
TW:4426
|
Taiwan | NT$2.34 Billion |
Liability Composition Analysis (2014–2025)
This chart breaks down Yuhan Corp Preferred's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Yuhan Corp Preferred (000105) total assets.
Liquidity & Leverage Metrics
Yuhan Corp Preferred Total Liabilities Ratios Explained
Yuhan Corp Preferred total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 2.03 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.41 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.29 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Yuhan Corp Preferred's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Yuhan Corp Preferred (2014–2025)
The table below shows the annual total liabilities of Yuhan Corp Preferred from 2014 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | ₩858.64 Billion ≈ $581.89 Million |
+8.50% |
| 2024-12-31 | ₩791.38 Billion ≈ $536.31 Million |
+88.70% |
| 2023-12-31 | ₩419.38 Billion ≈ $284.21 Million |
-9.80% |
| 2022-12-31 | ₩464.92 Billion ≈ $315.07 Million |
-11.93% |
| 2021-12-31 | ₩527.92 Billion ≈ $357.77 Million |
-3.49% |
| 2020-12-31 | ₩547.02 Billion ≈ $370.71 Million |
+17.08% |
| 2019-12-31 | ₩467.21 Billion ≈ $316.62 Million |
-10.51% |
| 2018-12-31 | ₩522.08 Billion ≈ $353.80 Million |
+6.91% |
| 2017-12-31 | ₩488.35 Billion ≈ $330.95 Million |
-11.11% |
| 2016-12-31 | ₩549.39 Billion ≈ $372.31 Million |
+6.39% |
| 2015-12-31 | ₩516.39 Billion ≈ $349.95 Million |
+51.83% |
| 2014-12-31 | ₩340.11 Billion ≈ $230.49 Million |
-- |
About Yuhan Corp Preferred
Yuhan Corporation operates as a pharmaceutical company in South Korea and internationally. It offers manufacturing services, such as custom manufacturing; process research and development of active pharmaceutical products (APIs) and intermediates; kilo and pilot-scale production of APIs and intermediates; commercial production of APIs and intermediates; production of chemical specialties; and ana… Read more